Literature DB >> 20141563

Weak associations between human leucocyte antigen genotype and acute myocardial infarction.

H Björkbacka1, E H Lavant, G N Fredrikson, O Melander, G Berglund, J A Carlson, J Nilsson.   

Abstract

OBJECTIVES: Human leucocyte antigens (HLAs) are polymorphic molecules involved in antigen presentation. Associations between HLA type and autoimmune diseases, such as type 1 diabetes and rheumatoid arthritis, are well established but the potential association of genetic variation affecting antigen presentation with cardiovascular disease has not been systematically investigated in large cohorts. The importance of such studies is stressed by recent experimental findings of an involvement of autoimmunity in the atherosclerotic disease process.
RESULTS: An SSP-PCR method was used for HLA genotyping to determine associations of HLA-DRB1, -DQA1 and -DQB1 with cardiovascular disease in a population-based cohort of 1188 acute myocardial infarction (AMI) patients and 1191 matched healthy controls. The HLA-DRB1*0101 allele, as well as the HLA-DRB1*0101-DQA1*01-DQB1*05 haplotype, was found to be associated with increased risk for AMI (OR 1.24; 95% CI 1.00-1.54 for both). In contrast, the DRB1*07 and DQA*02 alleles (OR 0.78; 95% CI 0.65-0.95 for both), as well as the DRB1*07-DQA*02-DQB*02 haplotype, conferred protection (OR 0.79; 95% CI 0.63-0.98). An HLA risk score taking each individual's both haplotypes into account was higher amongst cases (2.43 +/- 0.92 vs. 2.29 +/- 0.95, P = 0.001). The association between HLA risk score and AMI was independent of other cardiovascular risk factors assessed.
CONCLUSIONS: This study demonstrates that the associations between HLA-DRB1 and DQA1 loci and cardiovascular disease exists but that they are considerably weaker than those previously reported for other diseases with an established autoimmune aetiology such as type 1 diabetes, systemic lupus erythematosus and rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20141563     DOI: 10.1111/j.1365-2796.2009.02209.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  8 in total

Review 1.  Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure.

Authors:  Kerry Wright; Cynthia S Crowson; Sherine E Gabriel
Journal:  Heart Fail Clin       Date:  2014-01-10       Impact factor: 3.179

2.  HLA class II is a factor in cardiovascular morbidity and mortality rates in patients with type 1 diabetes.

Authors:  J Söderlund; C Forsblom; J Ilonen; L M Thorn; J Wadén; M Parkkonen; P-H Groop
Journal:  Diabetologia       Date:  2012-08-17       Impact factor: 10.122

3.  Genome-wide association study of coronary artery disease in the Japanese.

Authors:  Fumihiko Takeuchi; Mitsuhiro Yokota; Ken Yamamoto; Eitaro Nakashima; Tomohiro Katsuya; Hiroyuki Asano; Masato Isono; Toru Nabika; Takao Sugiyama; Akihiro Fujioka; Nobuhisa Awata; Keizo Ohnaka; Masahiro Nakatochi; Hidetoshi Kitajima; Hiromi Rakugi; Jiro Nakamura; Takayoshi Ohkubo; Yutaka Imai; Kazuaki Shimamoto; Yukio Yamori; Shuhei Yamaguchi; Shotai Kobayashi; Ryoichi Takayanagi; Toshio Ogihara; Norihiro Kato
Journal:  Eur J Hum Genet       Date:  2011-10-05       Impact factor: 4.246

Review 4.  The immunology of atherosclerosis.

Authors:  Anton Gisterå; Göran K Hansson
Journal:  Nat Rev Nephrol       Date:  2017-04-10       Impact factor: 28.314

5.  Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation.

Authors:  Sarah Louise Mackie; John C Taylor; Lubna Haroon-Rashid; Stephen Martin; Bhaskar Dasgupta; Andrew Gough; Michael Green; Lesley Hordon; Stephen Jarrett; Colin T Pease; Jennifer H Barrett; Richard Watts; Ann W Morgan
Journal:  Arthritis Res Ther       Date:  2015-07-30       Impact factor: 5.156

Review 6.  Emerging families of biomarkers for coronary artery disease: inflammatory mediators.

Authors:  Josef Yayan
Journal:  Vasc Health Risk Manag       Date:  2013-07-31

7.  Sex as a Determinant of Responses to a Coronary Artery Disease Self-Antigen Identified by Immune-Peptidomics.

Authors:  Wai Man Lio; Bojan Cercek; Juliana Yano; Wei Yang; Jonathan Ghermezi; Xiaoning Zhao; Jianchang Zhou; Bo Zhou; Michael R Freeman; Kuang-Yuh Chyu; Prediman K Shah; Paul C Dimayuga
Journal:  Front Immunol       Date:  2020-04-21       Impact factor: 7.561

8.  Pleiotropy in the Genetic Predisposition to Rheumatoid Arthritis: A Phenome-Wide Association Study and Inverse Variance-Weighted Meta-Analysis.

Authors:  Vivian K Kawai; Mingjian Shi; Qiping Feng; Cecilia P Chung; Ge Liu; Nancy J Cox; Gail P Jarvik; Ming T M Lee; Scott J Hebbring; John B Harley; Kenneth M Kaufman; Bahram Namjou; Eric Larson; Adam S Gordon; Dan M Roden; C Michael Stein; Jonathan D Mosley
Journal:  Arthritis Rheumatol       Date:  2020-08-06       Impact factor: 15.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.